Learn More
7511 Background: Although patients (pts) with MCL have a high response rate to standard chemotherapy, they continue to relapse with no plateau in long term disease-free survival. The use of dose(More)
e18509 Background: Advanced stage FL 1-2 is considered incurable with conventional therapies. Randomized trials over the past decade have demonstrated a survival advantage associated with the use of(More)
  • 1